Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Daily News

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

Yael L. Maxwell

December 07, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

Todd Neale

September 22, 2017

Presentation iASSESS 2017

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in those Undergoing PCI

Presenter: Sripal Bangalore

August 30, 2017

Presentation ESC 2017

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

Presenter: Martin J. Holzmann

August 28, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

CMS Reverses Its Course on Bundled Payments for MI, CABG

Caitlin E. Cox

August 16, 2017

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Todd Neale

July 20, 2017

Presentation

Predictors of Long-term Major CV Events and Death in Patients With Unprotected Left Main CAD

July 20, 2017

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

Presentation ACC 2017

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

Presenter: Magnus Ohman

March 27, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Daily News

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

L.A. McKeown

February 27, 2017

Presentation CHIP Florida 2017

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Presenter: Tanveer Rab

January 21, 2017

CME

Advertisement

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in those Undergoing PCI

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

CMS Reverses Its Course on Bundled Payments for MI, CABG

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Predictors of Long-term Major CV Events and Death in Patients With Unprotected Left Main CAD

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content